These differences were highly significant for all three variants between subgroups of younger (20-50 y.o. n = 25) and older (>50 y.o. n = 25) adults in our cohort (Fig. 1i ).
← all excerpts
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum.
1
—
—